Project Details
| Short title | CA017-078 |
|---|---|
| Status | Active |
| Effective start/end date | 6/08/19 → 18/06/24 |
A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer.
- Zhang, Alison (Primary Chief Investigator)
- Chapman, Nicola (Chief Investigator)
- Butala, Radhika (Chief Investigator)
Project: Other